Inotuzumab Ozogamicin

Category: Cancer



Inotuzumab Ozogamicin Overview

Inotuzumab ozogamicin (trade name Besponsa) is an antibody-drug conjugate used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).[1][2] The medication consists of the humanized monoclonal antibody against CD22 (inotuzumab), linked to a cytotoxic agent from the class of calicheamicins called ozogamicin.[3] This drug was discovered by scientists collaborating at Celltech and Wyeth, and it was developed by Pfizer w...

Read more Inotuzumab Ozogamicin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Inotuzumab_ozogamicin

Recent Inotuzumab Ozogamicin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Inotuzumab Ozogamicin
  • Powder, For Injection Solution, Lyophilized Powder: 0.9/mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Inotuzumab Ozogamicin or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA